RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2016 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Medical Officer Raj Malik, MD, will present a company overview at the Wedbush PacGrow Healthcare Conference. The presentation will take place on Wednesday, August 17, at 1:55 p.m. ET at the Le Parker Méridien in New York City.

For additional information on the conference, visit:
https://www.wedbush.com/services/cmg/equities-division/mgmt-access-events

About G1 Therapeutics, Inc.

G1 Therapeutics is a clinical-stage oncology company developing novel, small-molecule therapies that address significant unmet needs in people with cancer. The company is advancing G1T28, a potential first-in-class drug candidate, and G1T38, a potential best-in-class compound, in multiple oncology indications. G1 is privately held and based in Research Triangle Park, NC.

Visit www.g1therapeutics.com for more information.

Contact:                                                               
Gregory Mossinghoff
G1 Therapeutics                                               
919-251-5980
gjm@g1therapeutics.com

Media:
Laura Bagby                      
6 Degrees Communications
312-448-8098
lbagby@6degreespr.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.